Translating Animal Models of Ischemic Stroke to the Human Condition

Area of Science:

• Neuroscience
• Translational Medicine
• Neurology

Background:

• Ischemic stroke is a major cause of death and disability worldwide.
• Few neuroprotective agents successful in preclinical studies translate to human clinical trials.
• A key challenge is the incongruence between animal models and human ischemic stroke presentation.

Purpose of the Study:

• To provide a comprehensive summary of commonly used animal models for ischemic stroke research.
• To establish clear correlates between rodent models and clinical stroke pathologies.
• To guide the development of clinical trial designs that better match preclinical models for improved translation.

Main Methods:

• Review of existing literature on animal models of ischemic stroke.
• Analysis of preclinical study designs and their alignment with human stroke characteristics.
• Comparison of outcomes from preclinical studies using various animal models.

Main Results:

• Identified common rodent models used in preclinical ischemic stroke research.
• Detailed the specific clinical stroke pathologies that each animal model most closely aligns with.
• Highlighted the diversity in human populations compared to homogenous animal models.

Conclusions:

• Improving the correlation between preclinical animal models and human stroke conditions is critical for successful translation.
• Better-aligned models can lead to more accurate and efficient identification of novel neuroprotective agents.
• This approach can enhance the development of effective stroke therapies for improved patient outcomes.